Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
DHthis companyDefinitive Healthcare Corp.	$1.14	-2.21×	1.09×	1.27×	-2.22×	-728.9%	75.9%	-8.5%	-57.5%	-49.4%	-3.3%	12.1%	0.61×	-0.06×	-1.82×	1.64×	1.0%	6	-3.14	2	B-
CABACabaletta Bio, Inc.	$1.52	-1.34×	2×	0×	-1.02×	-65.7%	0.0%	0.0%	0.0%	-149.8%	-123.8%	-59.1%	0.24×	0.34×	-85.95×	2.77×	0.0%	2	-1.41	2	C+
EDITEditas Medicine, Inc.	$2.68	-1.14×	6.67×	4.49×	-0.75×	-308.6%	100.0%	-245.2%	-395.0%	-586.6%	-65.6%	-91.2%	2.81×	0.47×	-16.1×	3.54×	0.0%	3	-8.13	2	C
KYTXKyverna Therapeutics, Inc.	$5.09	-2.58×	1.79×	0×	-2.02×	-60.9%	0.0%	0.0%	0.0%	-69.4%	-65.0%	-36.9%	0.12×	0.6×	-347.29×	7.75×	0.0%	1	-0.9	2	C
NAKANakamoto Inc.	$5.60	-1.35×	0.31×	87.61×	-200.13×	-440.3%	-508.8%	-10824.0%	-2867.6%	-10.2%	-27.2%	-14.9%	0.41×	-4.17×	-27.92×	1.04×	0.0%	1	-4.78	2	C+
NRCNRC Health	$26.06	36.1×	30.03×	3.06×	16.38×	-50.4%	56.3%	16.4%	8.4%	82.9%	14.4%	3.7%	5.65×	2.48×	4.74×	0.55×	2.6%	7	3.22	2	C
Peer median	—	-1.34×	2×	3.06×	-1.02×	-65.7%	0.0%	0.0%	0.0%	-69.4%	-65.0%	-36.9%	0.41×	0.47×	-27.92×	2.77×	0.0%	2	-1.41	2	—